Get startedLog in
    Picture of Natco Pharma logo

    NATCOPHARM — Natco Pharma Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareAdventurousMid CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Natco Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    2026
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line2,0228,61916,73522,91414,908
    Depreciation
    Non-Cash Items-187-618-530-2,575-1,769
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital-2,796-1,148-5,957-5,7232,478
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities4658,49112,11616,96817,683
    Capital Expenditures-2,328-2,056-3,587-5,116-3,911
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items2,275-2,715-6,740-9,029-16,906
    Acquisition of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Change in Net Intangibles
    Other Investing Cash Flow
    Cash from Investing Activities-53-4,771-10,327-14,145-20,817
    Financing Cash Flow Items-188-142-181-176-359
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities348-3,630-2,469-2,1072,975
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash853208-615496789